Remdesivir Expanded Access

Note: This trial is no longer recruiting new patients.


Objective

Due to the lack of proven treatment options for COVID-19, the only medical intervention currently available to patients who develop severe or life-threatening illness is supportive care. Developing and researching potential treatments in an expedited fashion is a priority in combating this disease. Remdesivir is an investigational medication that has been approved by the FDA for compassionate use in patients with COVID-19 who have developed severe or life-threatening illness. Remdesivir is an antiviral medication that is designed to prevent proliferation of the virus within the body. It has been tested in hundreds of patients with SARS-CoV-2, the virus that causes COVID-19, and preliminary results suggest that the medication may improve clinical outcomes and prevent further disease progression.

Sponsor

Principal Investigator

Contact

Location

Overlake Medical Center
1035 116th Ave NE 
Bellevue, WA 98004

Phone: (425) 688-5000

Resources

  • ClinicalTrials.gov: Use NCT04323761 as the identifier to view a full description of this study.